Le Lézard
Classified in: Health
Subject: VET

Consider Supporting Hospitalized Veterans on Giving Tuesday


BALTIMORE, Nov. 14, 2019 /PRNewswire-PRWeb/ -- With Giving Tuesday on Dec. 3, 2019, the Veterans Affairs (VA) Maryland Health Care System reminds community members, businesses and organizations about the benefits of supporting local hospitalized veterans throughout Maryland. Created in 2012, Giving Tuesday is a global movement that inspires hundreds of millions of people to give, collaborate and celebrate generosity before the holidays, and enables participants to turn good intentions into action.

Each year, hundreds of Veterans spend the holidays at a VA Maryland Health Care System inpatient facility. Many of these hospitalized veterans may not have an opportunity to see family members and friends during the holiday season. On Giving Tuesday and throughout the year, community members, corporate donors and other organizations can support veteran inpatients by making a donation to the VA Maryland Health Care System's Holiday Gift Program, which provides gift packages valued at $70 for each hospitalized veteran at the Baltimore, Loch Raven and Perry Point VA Medical Centers during the holiday season.

"The holidays can be a very lonely and challenging time of the year for many people, but this is even more evident for veterans who are hospitalized and far from their loved ones," says Dr. Adam M. Robinson, Jr., director of the VA Maryland Health Care System. "GivingTuesday is a wonderful opportunity to support the needs of our hospitalized veterans this holiday season and to remind them that their service in the armed forces has not been forgotten."

To make a donation, visit http://www.maryland.va.gov and click on "Volunteer or Donate" on the left side of the landing page, or call 410-642-2411, ext. 25409.    
# # #

The VA Maryland Health Care System (VAMHCS) is a dynamic and progressive health care organization that is dedicated to providing safe, quality and compassionate care to Maryland's veterans. The Baltimore, Loch Raven and Perry Point VA Medical Centers, in addition to Cambridge, Eastern Baltimore County, Fort Meade, Glen Burnie and Pocomoke City VA Outpatient Clinics, all work together to form this integrated health care delivery system. Nationally recognized for its quality patient care and cutting-edge technology, the VAMHCS is proud of its reputation as a leader in veterans' health care, research and education. The health care system is known for providing comprehensive services to veterans in Central Maryland and on Maryland's Eastern Shore, including medical, surgical, rehabilitative, neurological, primary, mental health and long-term care on both an inpatient and outpatient basis. More than 53,000 veterans receive their care from the VAMHCS annually. All veterans are encouraged to apply for VA health care by calling 877-222-8387 or visiting http://www.va.gov.

 

SOURCE Veterans Affairs (VA) Maryland Health Care System


These press releases may also interest you

at 16:12
SummaryProducts: Cetrotide 0.25mg Issue: One lot of Cetrotide 0.25mg is being recalled because some vials may have missing stoppers, which could make the product unsterile. What to do: Check the lot number on your product or contact your pharmacist...

at 12:00
In lieu of an in-person update to the media, Dr. Theresa Tam, Canada's Chief Public Health Officer, issued the following statement today: "There have been 105,091 cases of COVID-19 in Canada, including 8,663 deaths. 65% of people have now recovered....

at 11:00
The latest data of the evolution of COVID-19 in Québec reveal 102 new cases over the past 24 hours, bringing the total number of people infected to 55,784. During the same period, 3 new deaths were recorded, to which are added 3 deaths that occurred...

at 10:37
On Friday, the British government announced that, as of July 10th, those travelling from the Commonwealth of Dominica to England need not self-isolate for 14 days. Dominica is one of the 59 countries and 14 British Overseas Territories forming a...

at 03:05
Gilead Sciences, Inc. today announced data from an ongoing Phase 1 study, which showed that a sustained-delivery subcutaneous formulation of the company's investigational, novel inhibitor of HIV-1 capsid function, lenacapavir (GS-6207), sustained...

at 03:05
Gilead Sciences, Inc. today announced data demonstrating the safety and efficacy of the once-daily, single tablet regimen Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets, B/F/TAF) in virologically suppressed...



News published on 14 november 2019 at 19:00 and distributed by: